_:ne6f63ce7da374884a99e9adfe5e51f5fxb1
<http://schema.org/url>
<https://www.novartis.com/sites/novartis_com/files/novartis-logo-open-graph.jpg>
<https://www.novartis.com/news/media-releases/sandoz-announces-exclusive-deal-commercialize-biosimilar-ustekinumab-further-reinforcing-growing-pipeline-and-immunology-patient-offering>